Publication | Closed Access

Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis

VaccinationMucosal VaccinationCellular VaccinationMurine ModelImmunologyTherapeutic VaccineAutoimmunityT Cell ImmunityDendritic Cell BiologyVaccine DesignImmunotherapyMedicineCell BiologyVisceral Leishmaniasis